Lancashire Teaching Hospitals NHS
Preston, Lancashire, PR2 9HT, United Kingdom
Location status: Recruiting
Location contact
Arnab Bhowmick
PRINCIPAL_INVESTIGATOR
Kina Bennett
CONTACT
(+44) 01772 522031
Research Access
CONTACT
NCT Number: NCT06288464
Following surgical removal of diseased bowel, patients often require a temporary redirection of bowel contents to a stoma, to allow healing prior to re-joining of the remaining bowel at a later date. Some patients may experience complications, either during or after reversal surgery, and this may be due to changes in the 'friendly' bacteria that live in our bowels. Previous research shows that the distal section of bowel that is non-functioning undergoes tissue-wasting and the 'friendly' bacteria that help our digestion die. Data shows that patients that have a reduction in their microflora are more likely to experience side effects. This study investigates a method of replenishing the microflora prior to surgery.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Preston, Lancashire, PR2 9HT, United Kingdom
Location status: Recruiting
Arnab Bhowmick
PRINCIPAL_INVESTIGATOR
Kina Bennett
CONTACT
(+44) 01772 522031
Research Access
CONTACT
Surgical formation of a loop ileostomy to divert the faecal stream and allow tissue healing, with the aim of re-joining the bowel around 1 year later, is carried out in around 9000 patient per year in the United Kingdom (UK). One in 4 patients experience severe side effects, such as inflammation or lack of function following reversal, and 5% of patients cannot undergo reversal, leaving them with a permanent stoma. Previous data shows that patients with less bacteria in the distal bowel may be more likely to develop post-operative complications. This study investigates a method of replenishing the microflora prior to surgery. The data also shows that patients with less bacteria in the distal bowel may be more likely to develop post-operative complications.
This study will pilot a clinical trial to assess whether enteral feeding in these 'high risk' patients alters the microflora, prior to applying to complete a randomised, controlled trial to assess the effectiveness of enteral feeding in standard-care patients. The enteral feeding is carried out through a feeding tube into the defunctioned part of the stoma. Initially patients receive saline and build up to approximately 100ml of 'Ensure™', a nutrition shake containing 9 amino acids and various vitamins and minerals, over a period of approximately 4 weeks. A source of fibre will be added to the shake, a Chicory root extract made by BENEO™, for the final week to 10 days of stoma feeding. There is evidence to support that oral consumption, in both adult and paediatric patients, of the chicory root extract supports positive microflora growth. We propose to supplement Ensure™ with up to 10g of chicory root extract for the final 7-10 days of stoma feeding and assess the changes on both the microbiota and on the histological and biomolecular properties of the intestinal tissues.
This research aims to investigate ways to increase the numbers of friendly bacteria to improve the health of the distal, non-functioning, bowel by adding fibre to the nutritional supplement fed to the distal bowel for around two weeks prior to surgery. The aim is that this will reduce the risk of complications and possibly reduce the recovery time from bowel surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will be assigned to stoma feeding by the Colorectal Surgeon, which will be managed by the stoma nurses for the duration, approximately 4 weeks, of feeding. For the final 7-14 days (minimum 7 days) of feeding, 10g of soluble fibre will be added to 100ml of Ensure™ (or equivalent liquid nutrient feed) before instillation into the stoma on a daily basis. The soluble fibre will be provided in 10g portions and should be added to the newly-opened bottle of ensure and shaken to mix well.
Time frame: 1 month
16S rRNA sequencing and qPCR, comparing de-functioned and functional limbs of the ileostomy.
Biomolecular analysis of the tissues, to assess growth and inflammation, using histological techniques to quantify and identify the microbiota.
Time frame: 1 month
Immune cell populations will be identified and profiled using flow cytometric analysis and/or immunohistochemistry.
Time frame: 1 month
Length of stay in hospital
Time frame: 1 month
Clinical observations or complications (e.g. anastomotic leak, ileus, excessive distention/bloating or wound infection) will be recorded.
Along with information regarding Patient BMI, sex, date of stoma creation, and history of antibiotic usage (name/duration) during the time stoma was in place should also be recorded.
Contact information is provided by the study sponsor or research team.
Lancashire Teaching Hospitals NHS Foundation Trust
Other
Does Distal Enteral Feeding of Fibre Positively Affect the Microflora in the Distal Limb of Loop Ileostomy Patients?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06315179
Anorectal Disorder, Bile Duct Diseases
Seattle, Washington, United States
View Trial DetailsNCT06587841
Autonomic Dysfunction, Autonomic Nervous System Diseases
Vancouver, British Columbia, Canada
View Trial DetailsNCT05380856
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Odense, Fyn, Denmark
View Trial DetailsNCT06311110
Bowel Dysfunction, Developmental Coordination Disorder
Ghent, East Flanders, Belgium
View Trial Details